Business description not available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 12M | 0 |
| Net Income | -37M | -37M | -24M | -35M | -23M | -20M |
| EPS | $-0.31 | $-0.31 | $-0.24 | $-0.35 | $-0.25 | $-0.24 |
| Free Cash Flow | -25M | -25M | -38M | -21M | -31M | -33M |
| ROIC | -66.8% | -244.5% | -121.7% | -45.5% | -23.1% | -28.8% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | 0.85 | 1.25 | 0.42 | 0.23 | 0.33 |
| Dividends/Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -39M | -39M | -33M | -31M | -28M | -28M |
| Operating Margin | 0.0% | - | - | - | -235.4% | - |
| ROE | -223.4% | -223.4% | -143.0% | -86.7% | -29.1% | -34.0% |
| Shares Outstanding | 132M | 132M | 101M | 100M | 98M | 84M |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 0 | 12M | 0 | 0 | 0 | 0 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | -31M | -39M | -34M | -32M | -37M | -37M |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | -28M | -28M | -31M | -33M | -39M | -39M |
| Op. Margin | N/A | -235.4% | N/A | N/A | N/A | 0.0% |
| Net Income | -20M | -23M | -35M | -24M | -37M | -37M |
| Net Margin | N/A | -195.5% | N/A | N/A | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||||
| ROIC | -28.8% | -23.1% | -45.5% | -121.7% | N/M | -66.8% |
| ROE | -34.0% | -29.1% | -86.7% | -143.0% | -223.4% | -223.4% |
| ROA | -20.2% | -19.2% | -49.4% | -49.4% | -80.5% | -80.5% |
| Cash Flow | ||||||
| Op. Cash Flow | -33M | -31M | -21M | -38M | -25M | -25M |
| Free Cash Flow | -33M | -31M | -21M | -38M | -25M | -25M |
| Owner Earnings | -35M | -37M | -26M | -40M | -27M | -27M |
| CapEx | 0 | 0 | 0 | 0 | 0 | 0 |
| Maint. CapEx | 0 | 3.0M | 1.8M | 1.7M | 1.4M | 1.4M |
| Growth CapEx | N/A | N/A | N/A | N/A | N/A | 0 |
| D&A | 0 | 3.0M | 1.8M | 1.7M | 1.4M | 1.4M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 48K | 48K |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | 2.0M | 3.5M | 2.8M | 315K | 614K | 614K |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | ||||||
| Net Debt | 13M | 11M | 12M | 4.2M | -4.0M | -18M |
| Cash & Equiv. | 6.1M | 7.0M | 4.6M | 17M | 18M | 18M |
| Long-Term Debt | 19M | 18M | N/A | N/A | N/A | N/A |
| Debt/Equity | 0.33 | 0.23 | 0.42 | 1.25 | 0.85 | 0.00 |
| Interest Coverage | N/A | N/A | N/A | N/A | N/A | N/A |
| Equity | 58M | 79M | 40M | 17M | 16M | 16M |
| Total Assets | 98M | 120M | 70M | 49M | 46M | 46M |
| Total Liabilities | 40M | 41M | 30M | 32M | 29M | 29M |
| Intangibles | 0 | 0 | 0 | 87K | 67K | 67K |
| Retained Earnings | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital | 20M | 56M | 36M | 8.6M | 7.2M | 7.2M |
| Current Assets | 35M | 73M | 49M | 20M | 22M | 22M |
| Current Liabilities | 16M | 17M | 13M | 11M | 15M | 15M |
| Per Share Data | ||||||
| EPS | -0.24 | -0.25 | -0.35 | -0.24 | -0.31 | -0.31 |
| Owner EPS | -0.42 | -0.38 | -0.26 | -0.39 | -0.21 | -0.21 |
| Book Value | 0.69 | 0.81 | 0.40 | 0.17 | 0.12 | 0.12 |
| Cash Flow/Share | 0.00 | -0.21 | -0.33 | -0.22 | -0.27 | -0.27 |
| Dividends/Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shares Out. | 83.8M | 97.8M | 100.2M | 100.9M | 132.3M | 132.3M |
| Valuation | ||||||
| P/E Ratio | -8.5 | -11.7 | -5.5 | -6.3 | -2.3 | -2.5 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | 3.0 | 3.6 | 4.8 | 9.0 | 5.9 | 6.2 |
| Price/Sales | N/A | 23.9 | N/A | N/A | N/A | N/A |
| FCF Yield | -19.2% | -10.8% | -11.2% | -24.6% | -26.3% | -24.9% |
| Market Cap | 172M | 282M | 190M | 153M | 97M | 102M |
| Avg. Price | 1.66 | 2.88 | 2.31 | 1.91 | 1.17 | 0.77 |
| Year-End Price | 2.05 | 2.89 | 1.90 | 1.51 | 0.73 | 0.77 |
TRANSGENE passes 0 of 9 quality checks, indicating weak fundamentals.
TRANSGENE (TNG-PA) has a 5-year average return on invested capital (ROIC) of -54.8%. This is below average and may indicate limited pricing power.
TRANSGENE (TNG-PA) has a market capitalization of $102M. It is classified as a small-cap stock.
TRANSGENE (TNG-PA) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 0.05%.
TRANSGENE (TNG-PA) generated $-25 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
TRANSGENE (TNG-PA) has a debt-to-equity ratio of 0.85. This indicates moderate leverage.
TRANSGENE (TNG-PA) reported earnings per share (EPS) of $-0.31 in its most recent fiscal year.
TRANSGENE (TNG-PA) has a return on equity (ROE) of -223.4%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 5 years of financial data for TRANSGENE (TNG-PA), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
TRANSGENE (TNG-PA) has a book value per share of $0.12, based on its most recent annual SEC filing.